You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 2, 2024

NEO-DELTA-CORTEF Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


When do Neo-delta-cortef patents expire, and when can generic versions of Neo-delta-cortef launch?

Neo-delta-cortef is a drug marketed by Pharmacia And Upjohn and is included in two NDAs.

The generic ingredient in NEO-DELTA-CORTEF is neomycin sulfate; prednisolone acetate. There are nineteen drug master file entries for this compound. Additional details are available on the neomycin sulfate; prednisolone acetate profile page.

AI Research Assistant
Questions you can ask:
  • What is the 5 year forecast for NEO-DELTA-CORTEF?
  • What are the global sales for NEO-DELTA-CORTEF?
  • What is Average Wholesale Price for NEO-DELTA-CORTEF?
Summary for NEO-DELTA-CORTEF
Drug patent expirations by year for NEO-DELTA-CORTEF
Recent Clinical Trials for NEO-DELTA-CORTEF

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
University of North Carolina, Chapel HillPhase 4
University Medical Center GroningenEarly Phase 1
Beth Israel Deaconess Medical CenterPhase 2

See all NEO-DELTA-CORTEF clinical trials

US Patents and Regulatory Information for NEO-DELTA-CORTEF

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Pharmacia And Upjohn NEO-DELTA-CORTEF neomycin sulfate; prednisolone acetate OINTMENT;OPHTHALMIC 061039-002 Approved Prior to Jan 1, 1982 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Pharmacia And Upjohn NEO-DELTA-CORTEF neomycin sulfate; prednisolone acetate OINTMENT;OPHTHALMIC 061039-001 Approved Prior to Jan 1, 1982 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Pharmacia And Upjohn NEO-DELTA-CORTEF neomycin sulfate; prednisolone acetate SUSPENSION/DROPS;OPHTHALMIC 061037-001 Approved Prior to Jan 1, 1982 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.